| Name | Deltex Medical Group |
|---|---|
| Epic | DEMG |
| Isin | GB0059337583 |
| Industry | Medical Equipment and Services |
| Latest share price | 0.09p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £1.61 | Debt ratio | n/a |
| Shares in issue | 1,896.03 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -105.94 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -0.11 | 52-week high / low | 0.09p / 0.18p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Deltex Medical Group |
|---|---|
| Address | Terminus Road, Chichester, West Sussex, United Kingdom, PO19 8TX |
| Telephone | |
| Website | http://www.deltexmedical.com/ |
| Director | Position |
|---|---|
| Mr Andy Mears | CEO |
| Ms Natalie Wettler | Finance Director |
| Mr Nigel J Keen | Chairman |
| Mr Tim (Timothy) Irish | Non-Executive Director |
| Mr Mark Wippell | Independent Non-Executive Director |
| Mr Charles Julian Cazalet | Independent Non-Executive Director |
| Mr Christopher Michael Jones | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 3.96 | 3.77 | 3.13 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 4.16 | 4.04 | 3.56 |
| Inventory / work in progress | 0.72 | 0.82 | 0.8 |
| Trade and other receivables | 0.18 | 0.46 | 0.46 |
| Cash and equivalents | 0.7 | 0.47 | 0.41 |
| Other current assets and asset held for resale | 0.17 | 0.23 | 0.18 |
| Total of all assets | 5.93 | 6.01 | 5.39 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 0.93 | 2.47 | 2.18 |
| Long term liabilities | 1.85 | 1.31 | 1.31 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 2.79 | 3.79 | 3.49 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 3.14 | 2.23 | 1.9 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 7.2 | 6.99 | 5.85 |
| Minority interests | -0.15 | -0.12 | -0.12 |
| Retained earnings | -57.77 | -56.57 | -55.59 |
| Share premium account | 35.65 | 33.67 | 33.5 |
| Total equity | 3.14 | 2.23 | 1.9 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -1.05 | -0.95 | -0.81 |
| Pre-tax profit | -1.28 | -1.15 | -0.98 |